<i>Roseburia intestinalis</i> generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 <sup>+</sup> T cells
2023 · Gut · 302 citations
https://doi.org/10.1136/gutjnl-2023-330291
F
Fenfen Ji
Jimei University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
2.4K
Citations
21
h-index
32
i10-index
Fenfen Ji is an academic researcher from Jimei University. The author has contributed to research in topics: RNA modifications and cancer & Metabolomics and Mass Spectrometry Studies & Liver Disease Diagnosis and Treatment. The author has an h-index of 21, co-authored 57 publications.
ORCID: 0000-0002-2265-7607Papers by this author
works<i>Lactobacillus gallinarum</i>-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
2023 · Gut · 217 citations
https://doi.org/10.1136/gutjnl-2023-329543
statTarget: A streamlined tool for signal drift correction and interpretations of quantitative mass spectrometry-based omics data
2018 · Analytica Chimica Acta · 195 citations
https://doi.org/10.1016/j.aca.2018.08.002
The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer
2022 · Nature Communications · 90 citations
https://doi.org/10.1038/s41467-022-31663-z
Study of BDE-47 induced Parkinson’s disease-like metabolic changes in C57BL/6 mice by integrated metabolomic, lipidomic and proteomic analysis
2019 · Journal of Hazardous Materials · 55 citations
https://doi.org/10.1016/j.jhazmat.2019.06.015
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
2023 · Nature Communications · 48 citations
https://doi.org/10.1038/s41467-023-39571-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat